← Leaderboards
Gui-Shuang Ying
University Of Pennsylvania
$6,242,688
Attributed
$7,171,451
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,171,451 · 12
By mechanism
R21$3,572,310 · 8
UG1$2,351,221 · 1
P30$744,264 · 2
R34$503,656 · 1
Top collaborators
- Elise B Ciner2 shared
- Megan E Collins2 shared
- Marjean T Kulp2 shared
- Cynthia Ann Toth2 shared
- Yong Chen1 shared
- Lifang He1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Michael R. Elliott$9,523,774
Others in their field
Top investigators on “Data Analyses”
- Jeffrey P Krischer · University Of South Florida$479,251,741
- David Heimbrook · Leidos Biomedical Research, Inc.$301,617,631
- James Dennis Neaton · Northwestern University$300,725,740
- Marian Ewell · The Emmes Company, Llc$247,026,851
- David R. Weir · University Of Michigan At Ann Arbor$203,832,019
- Richard A Gibbs · Baylor College Of Medicine$192,038,842
Research focus
Data AnalysesBlindnessSample SizeVisual AcuityLeadResourcesData SetResearch PersonnelEvaluationSecondary AnalysisNational Eye InstitutePreventTrainingProductivityVisionDatabasesMonitorRetinopathy Of PrematurityEnrollmentStatistical Data InterpretationData ManagementClinical TrialsImagePharmaceutical Preparations
Grant awards (26)
Identification of School-age Eye conditions Evaluation (ISEE)$236,650
R34 · FY2025 · EY
Identification of School-age Eye conditions Evaluation (ISEE)$267,006
R34 · FY2024 · EY
Biostatistics Module$206,754
P30 · FY2024 · EY · contact PI
Fluoromethelone as Adjunctive Medical Therapy for TT Surgery (FLAME) Trial$845,725
UG1 · FY2023 · EY · contact PI
Surrogate Augmented Deep Predictive Learning for Retinopathy of Prematurity$482,124
R21 · FY2023 · EY · contact PI
Biostatistics Module$206,754
P30 · FY2023 · EY · contact PI
Secondary Data Analysis for Neonates with Retinal OCT Imaging$201,860
R21 · FY2023 · EY
Fluoromethelone as Adjunctive Medical Therapy for TT Surgery (FLAME) Trial$329,425
UG1 · FY2022 · EY · contact PI
Secondary Data Analysis for Neonates with Retinal OCT Imaging$257,350
R21 · FY2022 · EY
Biostatistics Module$165,378
P30 · FY2022 · EY · contact PI
Fluoromethelone as Adjunctive Medical Therapy for TT Surgery (FLAME) Trial$370,281
UG1 · FY2021 · EY · contact PI
Secondary Analysis of Data from the Dry Eye Assessment and Management (DREAM) Study$193,099
R21 · FY2021 · EY · contact PI
Biostatistics Module$165,378
P30 · FY2021 · EY · contact PI
Fluoromethelone as Adjunctive Medical Therapy for TT Surgery (FLAME) Trial$373,054
UG1 · FY2020 · EY · contact PI
Secondary Analysis of Data from the Dry Eye Assessment and Management (DREAM) Study$254,772
R21 · FY2020 · EY · contact PI
Secondary Analysis of Data from G-ROP Study$207,465
R21 · FY2020 · EY · contact PI
Additional Analyses of the Data from the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) and CATT Follow-up Study (CATT FS)$201,250
R21 · FY2020 · EY · contact PI
Fluoromethelone as Adjunctive Medical Therapy for TT Surgery (FLAME) Trial$432,736
UG1 · FY2019 · EY · contact PI
Secondary Analysis of Data from G-ROP Study$263,417
R21 · FY2019 · EY · contact PI
Additional Analyses of the Data from the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) and CATT Follow-up Study (CATT FS)$256,521
R21 · FY2019 · EY · contact PI
Secondary Analysis of the Data from the Telemedicine Approaches to Evaluating Acute-phase ROP (e-ROP)$227,217
R21 · FY2016 · EY · contact PI
Secondary Analysis of the Data from the Telemedicine Approaches to Evaluating Acute-phase ROP (e-ROP)$194,381
R21 · FY2015 · EY · contact PI
Secondary Data Analysis of the Data from Comparison of AMD Treatments Trials$196,000
R21 · FY2014 · EY · contact PI
Secondary Data Analysis of the Data from Comparison of AMD Treatments Trials$240,000
R21 · FY2013 · EY · contact PI
Analysis of the Data from Vision in Preschoolers (VIP) Study$198,000
R21 · FY2010 · EY · contact PI
Analysis of the Data from Vision in Preschoolers (VIP) Study$198,854
R21 · FY2009 · EY · contact PI